BeOne Medicines Ltd. (ONC) Financial Statements
BeOne Medicines Ltd. (ONC) reported trailing twelve-month revenue of $6.1B (up 34.3% year on year) and net income of $655.7M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $1.3B.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ONCBeOne Medicines Ltd.Follow ONC — free
—
Price chart with a free account
- Market cap
- 42.9B
- P/E TTM
- 67.6
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.24 | 0.20 | 0.43 | 0.31 | 1.18 | 1.42 | 2.46 | 3.81 | 5.34 | 6.13 | |
| Gross profit | — | 0.23 | 0.17 | 0.36 | 0.24 | 1.01 | 1.13 | 2.08 | 3.22 | 4.67 | 5.45 | |
| Research & development | 0.10 | 0.27 | 0.68 | 0.93 | 1.29 | 1.46 | 1.64 | 1.78 | 1.95 | 2.15 | 2.29 | |
| Operating income | -0.12 | -0.10 | -0.71 | -0.96 | -1.66 | -1.44 | -1.79 | -1.21 | -0.57 | 0.45 | 0.92 | |
| Pre-tax income | -0.12 | -0.09 | -0.69 | -0.94 | -1.62 | -1.44 | -1.96 | -0.83 | -0.53 | 0.42 | 0.87 | |
| Income tax | 0.00 | 0.00 | -0.02 | 0.01 | 0.01 | 0.02 | 0.04 | 0.06 | 0.11 | 0.13 | 0.21 | |
| Net income | -0.12 | -0.09 | -0.67 | -0.95 | -1.62 | -1.46 | -2.00 | -0.88 | -0.64 | 0.29 | 0.66 | |
| Diluted EPS ($) | -0.30 | -0.17 | -0.93 | -1.22 | -1.47 | -1.21 | -1.49 | -0.65 | -0.47 | 0.19 | 0.43 | |
| Diluted shares (bn) | — | — | — | — | — | 1.206 | 1.341 | 1.357 | 1.369 | 1.475 | — |
USD billions · SEC XBRL
BeOne Medicines Ltd. — questions
- What is BeOne Medicines Ltd.'s revenue?
- $6.1B over the twelve months to 2026-06-30, up 34.3% year on year, from its 10-Q and 10-K filings.
- What is BeOne Medicines Ltd.'s net income?
- $655.7M over the twelve months to 2026-06-30.
- What is BeOne Medicines Ltd.'s free cash flow?
- $1.3B over the twelve months to 2026-06-30.
- What are BeOne Medicines Ltd.'s diluted earnings per share?
- $0.43 over the twelve months to 2026-06-30.
Every figure on this page comes from BeOne Medicines Ltd.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.